Stoke Therapeutics, Inc. (STOK)

31.62 -2.98% (-0.97)

Over 1M: +9.6%

2026-08-28
Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

30 32
31 Jul 5 Aug 10 Aug 13 Aug 18 Aug 21 Aug 26 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '23 — Revenue: 3.3M Q3 '23 — Operating Cash Flow: -17.3M Q3 '23 — Free Cash Flow: -17.6M Q3 '23 — Net Income: -24.5M Q4 '23 — Revenue: 2.8M Q4 '23 — Operating Cash Flow: -20.6M Q4 '23 — Free Cash Flow: -20.9M Q4 '23 — Net Income: -27M Q1 '24 — Revenue: 4.2M Q1 '24 — Operating Cash Flow: -24.6M Q1 '24 — Free Cash Flow: -24.6M Q1 '24 — Net Income: -26.4M Q2 '24 — Revenue: 4.8M Q2 '24 — Operating Cash Flow: -17.5M Q2 '24 — Free Cash Flow: -17.5M Q2 '24 — Net Income: -25.7M Q3 '24 — Revenue: 4.9M Q3 '24 — Operating Cash Flow: -21.6M Q3 '24 — Free Cash Flow: -21.7M Q3 '24 — Net Income: -26.4M Q4 '24 — Revenue: 22.6M Q4 '24 — Operating Cash Flow: -23.2M Q4 '24 — Free Cash Flow: -23.2M Q4 '24 — Net Income: -10.5M Q1 '25 — Revenue: 158.6M Q1 '25 — Operating Cash Flow: 131.8M Q1 '25 — Free Cash Flow: 131.7M Q1 '25 — Net Income: 112.9M Q2 '25 — Revenue: 13.8M Q2 '25 — Operating Cash Flow: -25.4M Q2 '25 — Free Cash Flow: -25.6M Q2 '25 — Net Income: -23.5M Q3 '25 — Revenue: 10.6M Q3 '25 — Operating Cash Flow: -30.4M Q3 '25 — Free Cash Flow: -30.5M Q3 '25 — Net Income: -38.3M Q4 '25 — Revenue: 1.4M Q4 '25 — Operating Cash Flow: -30.5M Q4 '25 — Free Cash Flow: -30.7M Q4 '25 — Net Income: -57.9M Q1 '26 — Revenue: 6.2M Q1 '26 — Operating Cash Flow: -60.6M Q1 '26 — Free Cash Flow: -60.9M Q1 '26 — Net Income: -50M Q2 '26 — Revenue: 9.3M Q2 '26 — Operating Cash Flow: -56.6M Q2 '26 — Free Cash Flow: -58.6M Q2 '26 — Net Income: -61.6M -50M 0 50M 100M 150M 200M
Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 135.7%
OE margin -790.6%
Oper. margin -809.7%
ROIC -334.7%
Accruals -7.6%
EBITDA margin -803.4%
FCF margin -654.9%
OCF margin -645.2%
Profit margin -753.6%
ROA -52.8%
ROCE -63.5%
ROE -60.2%
Gross margin —
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

3.7
RPO / sales 0.31×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
ND/EBITDA —
Interest cover -4856.0×
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 7.7×
Cash runway 1.6 yr
F-score 5.1 pts
Cash / Debt —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.0
Sales/sh Y/Y -87.4%
EPS Y/Y -461.2%
Sales Q/Q -32.5%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS next Y —
Sales CAGR 4Y —

3 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.